RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain - PubMed (original) (raw)
Shi Du Yan, Ram Kumar Submamaryan, Barbara LaRue, Suzana Jovanovic, Elizabeth Hogg, Deborah Welch, Lawrence Manness, Chang Lin, Jin Yu, Hong Zhu, Jorge Ghiso, Blas Frangione, Alan Stern, Ann Marie Schmidt, Don L Armstrong, Bernd Arnold, Birgit Liliensiek, Peter Nawroth, Florence Hofman, Mark Kindy, David Stern, Berislav Zlokovic
Affiliations
- PMID: 12808450
- DOI: 10.1038/nm890
RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain
Rashid Deane et al. Nat Med. 2003 Jul.
Abstract
Amyloid-beta peptide (Abeta) interacts with the vasculature to influence Abeta levels in the brain and cerebral blood flow, providing a means of amplifying the Abeta-induced cellular stress underlying neuronal dysfunction and dementia. Systemic Abeta infusion and studies in genetically manipulated mice show that Abeta interaction with receptor for advanced glycation end products (RAGE)-bearing cells in the vessel wall results in transport of Abeta across the blood-brain barrier (BBB) and expression of proinflammatory cytokines and endothelin-1 (ET-1), the latter mediating Abeta-induced vasoconstriction. Inhibition of RAGE-ligand interaction suppresses accumulation of Abeta in brain parenchyma in a mouse transgenic model. These findings suggest that vascular RAGE is a target for inhibiting pathogenic consequences of Abeta-vascular interactions, including development of cerebral amyloidosis.
Similar articles
- Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier.
Li M, Shang DS, Zhao WD, Tian L, Li B, Fang WG, Zhu L, Man SM, Chen YH. Li M, et al. J Immunol. 2009 May 1;182(9):5778-88. doi: 10.4049/jimmunol.0803013. J Immunol. 2009. PMID: 19380826 - Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
LaRue B, Hogg E, Sagare A, Jovanovic S, Maness L, Maurer C, Deane R, Zlokovic BV. LaRue B, et al. J Neurosci Methods. 2004 Sep 30;138(1-2):233-42. doi: 10.1016/j.jneumeth.2004.04.026. J Neurosci Methods. 2004. PMID: 15325132 - LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.
Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV. Deane R, et al. Neuron. 2004 Aug 5;43(3):333-44. doi: 10.1016/j.neuron.2004.07.017. Neuron. 2004. PMID: 15294142 - The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
Schmidt AM, Sahagan B, Nelson RB, Selmer J, Rothlein R, Bell JM. Schmidt AM, et al. Curr Opin Investig Drugs. 2009 Jul;10(7):672-80. Curr Opin Investig Drugs. 2009. PMID: 19579173 Review. - Clearing amyloid through the blood-brain barrier.
Zlokovic BV. Zlokovic BV. J Neurochem. 2004 May;89(4):807-11. doi: 10.1111/j.1471-4159.2004.02385.x. J Neurochem. 2004. PMID: 15140180 Review.
Cited by
- Increased Cellular Uptake of ApoE3- or c(RGD)-Modified Liposomes for Glioblastoma Therapy Depending on the Target Cells.
Lubitz LJ, Haffner MP, Rieger H, Leneweit G. Lubitz LJ, et al. Pharmaceutics. 2024 Aug 23;16(9):1112. doi: 10.3390/pharmaceutics16091112. Pharmaceutics. 2024. PMID: 39339149 Free PMC article. - Updates in Alzheimer's disease: from basic research to diagnosis and therapies.
Liu E, Zhang Y, Wang JZ. Liu E, et al. Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x. Transl Neurodegener. 2024. PMID: 39232848 Free PMC article. Review. - A review of the roles of pathogens in Alzheimer's disease.
Zhao M, Wang Y, Shen Y, Wei C, Zhang G, Sun L. Zhao M, et al. Front Neurosci. 2024 Aug 19;18:1439055. doi: 10.3389/fnins.2024.1439055. eCollection 2024. Front Neurosci. 2024. PMID: 39224577 Free PMC article. Review. - Blood-brain barrier disruption: a culprit of cognitive decline?
Che J, Sun Y, Deng Y, Zhang J. Che J, et al. Fluids Barriers CNS. 2024 Aug 7;21(1):63. doi: 10.1186/s12987-024-00563-3. Fluids Barriers CNS. 2024. PMID: 39113115 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases